Benzinga··NaAthyrium Backs Esperion's $50M Japan Deal to Fund Corstasis Acquisition
Athyrium invests $50M in Esperion via Japan royalty financing to fund Corstasis acquisition, bringing first FDA-approved intranasal loop diuretic to portfolio.
ESPRM&AJapan market